Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a nex ...
This company is leading the charge in methane abatement by transforming orphan wells into sustainable opportunities through innovative technology and carbon market expertise.